1. Functional roles of DDX41 mutations in the development of myeloid malignancies;Ayana Kon, Masahiro M Nakagawa, Hideki Makishima, Manabu Nakayama, Haruhiko Koseki;27th Congress of EHA,2022/6/9-17,Virtual,口頭
不明 / 口頭
2. Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms;Hideki Makishima, Yasuhito Nannya, June Takeda;64th ASH Annual Meeting and Exposition,2022/12/10,米国/ニューオーリンズ(In-Person/Virtual), 口頭
国外 / 口頭
3. Amplified EPOR/JAK2 genes definea unique subtype of acute erythroid leukemia;June Takeda , Kenichi Yoshida ,Hideki Makishima;American Association for Cancer Research Annual Meeting 2022, 2022/4/8-13,米国/ニューオーリンズ(In-Person/Virtual),ポスター
国外 / ポスター
4. Sequential acquisition of molecular defects in MDS;Hideki Makishima; JinLing MDS MPN summit forum,2022/9/17,中国/南京,口頭
国外 / 口頭
5. Amplified EPOR/JAK2 genes definea unique subtype of acute erythroid leukemia;June Takeda , Kenichi Yoshida , Hideki Makishima;The 27th Congress of the European Hematology Association,2022/6/10,オーストリア/ウィーン(In-Person/Virtual),ポスター
国外 / ポスター
6. Elucidating the mechanism of clonal evolution of DDX41 mutated cells in myeloid malignancies;Ayana Kon, Masahiro M Nakagawa, Hideki Makishima;第81回日本癌学会学術集会,2022/9/29,横浜,口頭
国内 / 口頭
7. Elucidating the mechanism of clonal evolution of DDX41 mutated cells in myeloid malignancies;Ayana Kon, Masahiro M Nakagawa, Hideki Makishima;第84回日本血液学会学術集会,2022/10/14,福岡,口頭
国内 / 口頭
8. Germline DDX41 mutations define a unique subtype of myeloid neoplasms;Hideki Makishima, Yasuhito Nannya, June Takeda;第81回日本癌学会学術集会;2022/9/29,横浜,口頭
国内 / 口頭
9. Germline DDX41 mutations define a unique subtype of myeloid neoplasms;Hideki Makishima, Yasuhito Nannya, June Takeda;第84回日本血液学会学術集会,2022/10/14,福岡,口頭
国内 / 口頭
10. 再生不良性貧血・発作性夜間血色素尿に潜むクローン性造血;牧島 秀樹;第84回日本血液学会学術集会,2022/10/16,福岡,口頭
国内 / 口頭